URGN icon

UroGen Pharma
URGN

Overview Fund Activity

149 hedge funds and large institutions have $545M invested in UroGen Pharma in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
2%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
40
Increased
45
Reduced
41
Closed
30
Calls
$35.4M
Puts
$14.1M
Net Calls
+$21.3M
Net Calls Change
+$20.2M

Top Buyers

1
SCM
Soleus Capital Management
Connecticut
+$29.9M
2
Morgan Stanley
Morgan Stanley
New York
+$22.2M
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$19.7M
4
JFG
Jefferies Financial Group
New York
+$19M
5
TCM
Tang Capital Management
California
+$13.7M

Top Sellers

1
UBS AM
UBS AM
Illinois
-$48.2M
2
RCM
RA Capital Management
Massachusetts
-$35.5M
3
VPC
Vestal Point Capital
New York
-$23.8M
4
NCM
Nantahala Capital Management
Connecticut
-$18.6M
5
MMH
Menora Mivtachim Holdings
Israel
-$15.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
BIG
176
Brooklyn Investment Group
New York
– -$819 -74 Closed
SC
177
SouthState Corp
Florida
– -$620 -56 Closed
CCM
178
Coldstream Capital Management
Washington
– -$321 -29 Closed
4 5 6 7
8